AzTrials
AzTrials

AnxietyNCT02288416

Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening

A study testing educational intervention, questionnaire administration and quality-of-life assessment in people with Anxiety and No Evidence of Disease, run by City of Hope Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This pilot trial studies a video-based intervention in reducing anxiety in patients undergoing lung cancer screening. Giving a video-based intervention to patients prior to lung cancer screening may reduce anxiety and improve the well-being and quality of life. Read more about this study

Who is it for?
Ages 55 years and olderHealthy volunteers can take part
Conditions the study is for
Anxiety, No Evidence of Disease, Lung Carcinoma
What is being tested?
educational intervention, questionnaire administration and quality-of-life assessment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
8 Dec 2014to 6 Sep 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • This study will be conducted in people scheduled to undergo baseline LDCT as part of the City of Hope (COH) LCS program
  • There are no restrictions related to performance status and life expectancy
  • All subjects must have the ability to understand and the willingness to participate in the informed consent process, although a waiver of written informed consent is obtained for this study

Who cannot join

  • Patients who do not speak or read, because all intervention materials, including the video and written materials are in English
  • Subjects, who in the opinion of the investigator, may not be able to comply with study procedures

Trial locations and contacts

1 site in 1 country.

United States1 site
  • City of Hope Medical Center

    Duarte, California, 91010

Other trials in United States

About this study

Official title: Pilot Study of a Video-Based Intervention to Reduce Psychological Harm Associated With Lung Cancer Screening

This pilot trial studies a video-based intervention in reducing anxiety in patients undergoing lung cancer screening. Giving a video-based intervention to patients prior to lung cancer screening may reduce anxiety and improve the well-being and quality of life.

Read the detailed description

PRIMARY OBJECTIVES:

  1. Test the feasibility and acceptability of the video-based intervention.

SECONDARY OBJECTIVES:

  1. To describe incidence, degree, and duration of screen-related anxiety among individuals scheduled to undergo low-dose computed tomography (CT) scan (LDCT) for lung cancer screening (LCS).

II. To describe baseline patient characteristics and pre-screening anxiety levels.

III. To describe the preliminary outcomes on screen-related anxiety for patients both not in the intervention group and those in the intervention group.

OUTLINE: Patients are assigned to 1 of 2 groups.

GROUP I: Patients receive standard of care following LCS consisting of routine visits and telephone contact with the LCS program nurse practitioner and coordinator.

GROUP II: Patients undergo a video-based intervention prior to undergoing LCS. Patients watch a 5-minute video that focuses on preparing patients for LCS by providing information on the following: program team and contact information; reason to be screened; screening eligibility; how screening is performed; what to expect on the day of screening; what to expect after screening; what to expect if result is positive; what to expect if result is negative; and risks of screening. Patients also receive an educational handbook. Patients with positive scans (a Lung-Imaging Reporting and Data Systems [RADS] 3 or 4) receive additional brochure and nursing support within 1 week after notification of scan results.

After completion of LCS, patients are followed up at 1 week and then at 3 and 7 months.

Being tested
educational intervention, questionnaire administration, quality-of-life assessment, Best Practice
Medical subject headings
Anxiety Disorders, Lung Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • educational interventionOther

    Also called intervention, educational

    Undergo video-based intervention

  • questionnaire administrationOther

    Ancillary studies

  • quality-of-life assessmentOther

    Also called quality of life assessment

    Ancillary studies

  • Best PracticeOther

    Also called standard of care, standard therapy

Study groups in NCT02288416
Study groupRoleWhat they receive
Group I (standard of care)Active comparatorPatients receive standard of care following LCS consisting of routine visits and telephone contact with the LCS program nurse practitioner and coordinator.
Receives: Other: questionnaire administration; Other: quality-of-life assessment; Other: Best Practice
Group II (video-based intervention)ExperimentalPatients undergo a video-based intervention prior to undergoing LCS. Patients watch a 5-minute video that focuses on preparing patients for LCS by providing information on the following: program team and contact information; reason to be screened; screening eligibility; how screening is performed; what to expect on the day of screening; what to expect after screening; what to expect if result is positive; what to expect if result is negative; and risks of screening. Patients also receive an educational handbook. Patients with positive scans (a Lung-RADS 3 or 4) receive additional brochure and nursing support within 1 week after notification of scan results.
Receives: Other: educational intervention; Other: questionnaire administration; Other: quality-of-life assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percent of patients who complete the intervention

    Descriptive statistics will be presented on participation in all components of the intervention.

    Measured: Baseline

  2. Patient satisfaction with the timing, content, and delivery of the video-based intervention assessed by survey

    This self-reported measure will be completed by subjects who received the intervention.

    Measured: Up to 7 months

Secondary outcomes (3)
  1. Patient screen-related anxiety as assessed by the mean score of the State Trait Anxiety Inventory (STAI)

    The survey is used to diagnose anxiety and to distinguish it from depressive syndromes, with items rated on a 4-point scale (with 1 being "Almost Never" and 4 being "Almost Always").

    Measured: Baseline to 7 months

  2. Health-related quality of life as assessed by the mean survey score of the Short Form-12 (SF-12) questionnaire

    The SF-12 is designed for assessment of general health status and contains 7 items that measure physical functioning, role functioning, bodily pain, energy/fatigue, social functioning, mental health, emotional functioning, general health perceptions, and changes in health.

    Measured: Up to 7 months

  3. Consequences of screening, assessed by the mean survey score of the Consequences of Screening in Lung Cancer (COS-LC) questionnaire

    This questionnaire is a non-validated adapted version of a validated two part tool used to assess the psychological impact to breast cancer screening using mammography.

    Measured: Up to 7 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Nov 2014 (estimated)
  2. Study start8 Dec 2014
  3. Primary completion6 Sep 2018
  4. Study completion6 Sep 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02288416
Sponsor's protocol ID
14169
Other IDs
NCI-2014-02220, 14169
Status last verified
Sep 2018
First submitted
7 Nov 2014
Last updated
10 Sep 2018
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing educational intervention, questionnaire administration and quality-of-life assessment in people with Anxiety and No Evidence of Disease, run by City of Hope Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percent of patients who complete the intervention (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in